
Christopher R. Stone
Examiner (ID: 10415, Phone: (571)270-3494 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1609, 1614, 1628, 4173 |
| Total Applications | 750 |
| Issued Applications | 250 |
| Pending Applications | 42 |
| Abandoned Applications | 457 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6084262
[patent_doc_number] => 20110144147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'INJECTABLE PHARMACEUTICAL COMPOSITIONS OF AN ANTHRACENEDIONE DERIVATIVE WITH ANTI-TUMORAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/964861
[patent_app_country] => US
[patent_app_date] => 2010-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1614
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144147.pdf
[firstpage_image] =>[orig_patent_app_number] => 12964861
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/964861 | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity | Dec 9, 2010 | Issued |
Array
(
[id] => 6121260
[patent_doc_number] => 20110077261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'PREVENTION OF HIV-INFECTION'
[patent_app_type] => utility
[patent_app_number] => 12/961305
[patent_app_country] => US
[patent_app_date] => 2010-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6532
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077261.pdf
[firstpage_image] =>[orig_patent_app_number] => 12961305
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/961305 | PREVENTION OF HIV-INFECTION | Dec 5, 2010 | Abandoned |
Array
(
[id] => 7662205
[patent_doc_number] => 20110311474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'Novel Tricyclic Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/958115
[patent_app_country] => US
[patent_app_date] => 2010-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 236424
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20110311474.pdf
[firstpage_image] =>[orig_patent_app_number] => 12958115
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/958115 | Tricyclic compounds | Nov 30, 2010 | Issued |
Array
(
[id] => 10056241
[patent_doc_number] => 09095581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Combinations of MEK inhibitors and Raf kinase inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/956177
[patent_app_country] => US
[patent_app_date] => 2010-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 30
[patent_no_of_words] => 68952
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12956177
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/956177 | Combinations of MEK inhibitors and Raf kinase inhibitors and uses thereof | Nov 29, 2010 | Issued |
Array
(
[id] => 10514897
[patent_doc_number] => 09241927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Pharmaceutical compositions comprising sigma receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 13/511706
[patent_app_country] => US
[patent_app_date] => 2010-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 10386
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511706
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/511706 | Pharmaceutical compositions comprising sigma receptor ligands | Nov 24, 2010 | Issued |
Array
(
[id] => 8612753
[patent_doc_number] => 20130018064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/511360
[patent_app_country] => US
[patent_app_date] => 2010-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27169
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511360
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/511360 | Amino heteroaryl compounds as beta-secretase modulators and methods of use | Nov 18, 2010 | Issued |
Array
(
[id] => 8725740
[patent_doc_number] => 08404858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-26
[patent_title] => 'Agent for regeneration and/or protection of nerves'
[patent_app_type] => utility
[patent_app_number] => 12/944326
[patent_app_country] => US
[patent_app_date] => 2010-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29003
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12944326
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/944326 | Agent for regeneration and/or protection of nerves | Nov 10, 2010 | Issued |
Array
(
[id] => 8483861
[patent_doc_number] => 20120283269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'Method and Compositions for Suppression of Aging'
[patent_app_type] => utility
[patent_app_number] => 13/505573
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 9176
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505573
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/505573 | Method and Compositions for Suppression of Aging | Nov 3, 2010 | Abandoned |
Array
(
[id] => 6007913
[patent_doc_number] => 20110059944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'Certain Substituted Amides, Method of Making, and Method of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/939518
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34948
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059944.pdf
[firstpage_image] =>[orig_patent_app_number] => 12939518
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/939518 | Certain substituted amides, method of making, and method of use thereof | Nov 3, 2010 | Issued |
Array
(
[id] => 5959681
[patent_doc_number] => 20110184068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'USE OF (HALOBENZYLOXY) BENZYLAMINO-PROPANAMIDES FOR THE MANUFACTURE OF MEDICAMENTS ACTIVE AS SODIUM AND/OR CALCIUM CHANNEL SELECTIVE MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/939726
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8377
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20110184068.pdf
[firstpage_image] =>[orig_patent_app_number] => 12939726
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/939726 | USE OF (HALOBENZYLOXY) BENZYLAMINO-PROPANAMIDES FOR THE MANUFACTURE OF MEDICAMENTS ACTIVE AS SODIUM AND/OR CALCIUM CHANNEL SELECTIVE MODULATORS | Nov 3, 2010 | Abandoned |
Array
(
[id] => 5986744
[patent_doc_number] => 20110098247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Substituted Dihydroquinazolines as Platelet ADP Receptor Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/912367
[patent_app_country] => US
[patent_app_date] => 2010-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23934
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098247.pdf
[firstpage_image] =>[orig_patent_app_number] => 12912367
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/912367 | Substituted Dihydroquinazolines as Platelet ADP Receptor Inhibitors | Oct 25, 2010 | Abandoned |
Array
(
[id] => 10019605
[patent_doc_number] => 09062076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Fused ring analogues of anti-fibrotic agents'
[patent_app_type] => utility
[patent_app_number] => 13/503160
[patent_app_country] => US
[patent_app_date] => 2010-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 30053
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503160
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503160 | Fused ring analogues of anti-fibrotic agents | Oct 20, 2010 | Issued |
Array
(
[id] => 10019605
[patent_doc_number] => 09062076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Fused ring analogues of anti-fibrotic agents'
[patent_app_type] => utility
[patent_app_number] => 13/503160
[patent_app_country] => US
[patent_app_date] => 2010-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 30053
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503160
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503160 | Fused ring analogues of anti-fibrotic agents | Oct 20, 2010 | Issued |
Array
(
[id] => 9875339
[patent_doc_number] => 08962606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-24
[patent_title] => 'Substituted benzosulphonamides'
[patent_app_type] => utility
[patent_app_number] => 13/502548
[patent_app_country] => US
[patent_app_date] => 2010-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29496
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502548
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/502548 | Substituted benzosulphonamides | Oct 6, 2010 | Issued |
Array
(
[id] => 7561885
[patent_doc_number] => 20110275718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'Pharmaceutical composition of ibuprofen and paracetamol and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 12/924812
[patent_app_country] => US
[patent_app_date] => 2010-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6064
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275718.pdf
[firstpage_image] =>[orig_patent_app_number] => 12924812
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/924812 | Pharmaceutical composition of ibuprofen and paracetamol and methods of using the same | Sep 29, 2010 | Abandoned |
Array
(
[id] => 8523409
[patent_doc_number] => 20120322817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 13/497576
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20043
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497576
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497576 | COMBINATION | Sep 22, 2010 | Abandoned |
Array
(
[id] => 8612782
[patent_doc_number] => 20130018094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'Prophylactic or Therapeutic Agent For Gum Disease or Apical Periodontitis'
[patent_app_type] => utility
[patent_app_number] => 13/497932
[patent_app_country] => US
[patent_app_date] => 2010-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3120
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497932 | Prophylactic or Therapeutic Agent For Gum Disease or Apical Periodontitis | Sep 20, 2010 | Abandoned |
Array
(
[id] => 8477785
[patent_doc_number] => 20120277193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'Synergistic Combination Therapy'
[patent_app_type] => utility
[patent_app_number] => 13/497272
[patent_app_country] => US
[patent_app_date] => 2010-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6891
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497272
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497272 | Synergistic Combination Therapy | Sep 19, 2010 | Abandoned |
Array
(
[id] => 8510434
[patent_doc_number] => 20120309842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'PROCESSES FOR THE PREPARATION OF CINACALCET'
[patent_app_type] => utility
[patent_app_number] => 13/496834
[patent_app_country] => US
[patent_app_date] => 2010-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11435
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496834
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/496834 | Processes for the preparation of cinacalcet | Sep 15, 2010 | Issued |
Array
(
[id] => 8398640
[patent_doc_number] => 08269017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Compounds for the treatment of proliferative disorders'
[patent_app_type] => utility
[patent_app_number] => 12/883883
[patent_app_country] => US
[patent_app_date] => 2010-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 23
[patent_no_of_words] => 59997
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12883883
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/883883 | Compounds for the treatment of proliferative disorders | Sep 15, 2010 | Issued |